The vaccine that goes by the name “mRNA jab” uses messenger RNA to prompt the body to make its immune defenses itself. Basically, a small amount of the coronavirus’ genetic code is injected into a human stimulating the body to produce its own immunity.
Vaccination is a process that requires the introduction of viral genetic material into a host system to produce a protective response from the host. Often delivered by injection, vaccination is the most effective way to get the protein response that would protect the host from the virus in the future. As Thailand was the first country to detect the COVID-19 virus outside of China, they are doing their best to be the first country to deliver a vaccine.
Thailand’s Minister of Higher Education, Science and Research and innovation, Suvit Maesincee told media that the vaccine testing had been advanced onto monkeys and they hoped to have a “clearer outcome of its efficacy by September. The team had chosen long-tailed Macaques monkeys to test the vaccine because they share a similar genetic structure to human subjects.
Suvit stressed that “This project is for the human race not just Thais…” and stressed that the endeavor was a world community collaborative effort to fight the pandemic. Despite this, the world health organization stressed that a vaccine would take at least twelve months to reach the public.
The World Health Organization has stated more than a hundred vaccine candidates in development with at least eight are already being tested on humans. Scientists and researchers from the University of Oxford are currently leading the race to a vaccine, and these scientists are currently testing variant viruses on chimpanzees that might get them closer to a vaccine to this pandemic.
The pharmaceutical giants’ Johnson & Johnson and Pfizer Inc are also racing to find a usable vaccine to counteract the devastating effects of the novel coronavirus. Moderna Inc therapeutics spearheaded the first trial of human vaccines in the United States. They showed promising results in a section of their healthy volunteers who exhibited the production of antibodies.
The director of the National Primate Research Centre of Thailand, Dr. Suchinda Malaivitjitnond supervised the vaccine injections to 13 monkeys on Saturday. Its common knowledge that a vaccine produced in Thailand would most likely be more cost-effective than the equivalent American or European made drugs.
By using mRNA the Thailand scientists are charting a new course in vaccine manufacturing as this genetic material has never been used in vaccine creation before and they are currently working with the University of Pennsylvania (USA) to test the proposed vaccine on monkeys to get it to the human testing phase as soon as October.